Day: October 20, 2025

VANCOUVER, British Columbia, Oct. 20, 2025 (GLOBE NEWSWIRE) — VR Resources Limited (“VR” or the “Company”, TSXV: VRR) is pleased to announce that it has entered into an agreement with Centurion One Capital Corp. (the “Lead Agent”) as lead agent and sole bookrunner in connection with a brokered private placement. The Company initially plans to raise up to $1.5M (the “Offering“) through the sale of up to 15M units (“Units“) at a post-Consolidation issue price of $0.10 per Unit (the “Issue Price”), on a commercially reasonable efforts basis. Each Unit shall consist of one common share in the capital of the Company (each, a “Share”) and one Share purchase warrant (each, a “Warrant”). Each full Warrant shall entitle the holder thereof to purchase one Share (a “Warrant Share”) at a post-Consolidation price of $0.16 (the “Exercise Price”)...

Prospectus Supplement and Base Shelf Prospectus Accessible on SEDAR+ NOT FOR ‎DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR THE ‎DISSEMINATION, DISTRIBUTION, ‎RELEASE OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES. TORONTO, Oct. 20, 2025 (GLOBE NEWSWIRE) — Allied Gold Corporation (TSX:AAUC) (NYSE: AAUC) (“Allied” or the “Company”) is pleased to announce that it has filed a prospectus supplement (the “Prospectus Supplement”) dated October 20, 2025, to its short form base shelf prospectus (the “Base Shelf Prospectus”) dated October 1, 2024, with the securities regulatory authorities in each of the provinces of Canada to qualify the public distribution of 6,400,000 common shares of the Company (the “Common Shares”) at an offering price (the “Offering Price”) of $27.35 per Common Share in connection with...

EMERYVILLE, Calif., Oct. 20, 2025 (GLOBE NEWSWIRE) — NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) (“NovaBay” or the “Company”) announces that it has regained compliance with the NYSE American’s continued listing standards. As previously disclosed, the NYSE American notified the Company on April 18, 2024 and May 28, 2024 that it was not in compliance with the continued listing standards of the NYSE American Company Guide. Specifically, the notifications indicated that the Company was not in compliance with Sections 1003(a)(i), 1003(a)(ii) and 1003(a)(iii) of the Company guide, requiring a listed company to have stockholders’ equity of at least $6 million. Following the issuance and sale of pre-funded warrants to purchase an aggregate of 5,405,406 shares of the Company’s common stock, par value...

NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) — HEALIOS K.K. (“Healios”) is pleased to announce that Richard Kincaid, Chief Financial Officer, will present at the Chardan 9th Annual Genetic Medicines Conference in New York City as follows: Date: Tuesday, October 21, 2025Time: 2:00pm, Eastern Time (US)Webcast: https://wsw.com/webcast/chard21/4593/1590729 To schedule a 1×1 meeting with Healios, please contact your Chardan representative at elevine@chardan.com The live and archived webcast will be accessible from Chardan’s website. The replay of the webcast will be accessible for 60 days. About Healios: HEALIOS K.K. is Japan’s leading clinical stage biotechnology company harnessing the potential of stem cells for regenerative medicine. It aims to offer new therapies for patients suffering from diseases without effective treatment...

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ TORONTO, Oct. 20, 2025 (GLOBE NEWSWIRE) — Abaxx Technologies Inc. (CBOE:ABXX) (“Abaxx” or the “Company”), a financial software and market infrastructure company, majority shareholder of Abaxx Singapore Pte Ltd., the owner of Abaxx Commodity Exchange and Clearinghouse (individually, “Abaxx Exchange” and “Abaxx Clearing”), and producer of the SmarterMarkets™ Podcast, is pleased to announce it has today closed a non-brokered private placement financing (the “Financing”) with a strategic investor (the “Investor”). The Financing consisted of the issuance of 1,000,000 units (the “Units”) of the Company at a price of US$22.00 per Unit for aggregate gross proceeds of US$22 million. Each Unit consists of one common share in the capital...

TORONTO, Oct. 20, 2025 (GLOBE NEWSWIRE) — Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSX.V: LFST; OTCQB: LFSWF; FRANKFURT: M5B0) today announced a change to its board of directors. John Sinclair has stepped down as a director and chair of the audit committee, effective October 20, 2025. The Company thanks Mr. Sinclair for his service and contributions. Following his departure, current director Branden Spikes has been named interim chair of the audit committee. Mr. Spikes has served on the Lifeist board since 2019. He has 20 years of experience working as Chief Information Officer for Elon Musk at Zip2, PayPal, Tesla, and SpaceX, where he helped pioneer, and build some extraordinary technology. Mr. Spikes brings experience, perspective, and a unique skill set to his endeavors. The board of directors now consists of Andrea...